X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES DISHMAN PHARMA ALKEM LABORATORIES/
DISHMAN PHARMA
 
P/E (TTM) x - 25.1 - View Chart
P/BV x 6.1 3.3 183.4% View Chart
Dividend Yield % 0.7 0.7 106.3%  

Financials

 ALKEM LABORATORIES   DISHMAN PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
DISHMAN PHARMA
Mar-16
ALKEM LABORATORIES/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,589374 424.4%   
Low Rs1,232129 955.8%   
Sales per share (Unadj.) Rs417.5197.8 211.1%  
Earnings per share (Unadj.) Rs56.321.2 265.5%  
Cash flow per share (Unadj.) Rs64.734.7 186.4%  
Dividends per share (Unadj.) Rs12.702.00 635.0%  
Dividend yield (eoy) %0.90.8 113.3%  
Book value per share (Unadj.) Rs292.9179.9 162.8%  
Shares outstanding (eoy) m119.5780.69 148.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.3 265.6%   
Avg P/E ratio x25.111.9 211.1%  
P/CF ratio (eoy) x21.87.2 300.8%  
Price / Book Value ratio x4.81.4 344.2%  
Dividend payout %22.69.4 239.2%   
Avg Mkt Cap Rs m168,65320,306 830.6%   
No. of employees `000NA0.8 0.0%   
Total wages/salary Rs m9,1715,355 171.3%   
Avg. sales/employee Rs ThNM19,252.7-  
Avg. wages/employee Rs ThNM6,459.5-  
Avg. net profit/employee Rs ThNM2,064.1-  
INCOME DATA
Net Sales Rs m49,91515,961 312.7%  
Other income Rs m1,645265 619.9%   
Total revenues Rs m51,56116,226 317.8%   
Gross profit Rs m8,4824,103 206.7%  
Depreciation Rs m1,0061,091 92.2%   
Interest Rs m671944 71.0%   
Profit before tax Rs m8,4512,334 362.1%   
Minority Interest Rs m-1140-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606624 257.5%   
Profit after tax Rs m6,7311,711 393.4%  
Gross profit margin %17.025.7 66.1%  
Effective tax rate %19.026.7 71.1%   
Net profit margin %13.510.7 125.8%  
BALANCE SHEET DATA
Current assets Rs m27,06211,018 245.6%   
Current liabilities Rs m15,3249,517 161.0%   
Net working cap to sales %23.59.4 250.1%  
Current ratio x1.81.2 152.5%  
Inventory Days Days67110 60.2%  
Debtors Days Days4135 118.5%  
Net fixed assets Rs m12,61016,304 77.3%   
Share capital Rs m239161 148.1%   
"Free" reserves Rs m34,49012,907 267.2%   
Net worth Rs m35,02714,516 241.3%   
Long term debt Rs m1,2124,189 28.9%   
Total assets Rs m54,38729,805 182.5%  
Interest coverage x13.63.5 391.9%   
Debt to equity ratio x00.3 12.0%  
Sales to assets ratio x0.90.5 171.4%   
Return on assets %13.68.9 152.8%  
Return on equity %19.211.8 163.0%  
Return on capital %24.917.5 141.8%  
Exports to sales %12.924.8 52.2%   
Imports to sales %3.13.7 82.6%   
Exports (fob) Rs m6,4613,956 163.3%   
Imports (cif) Rs m1,540596 258.3%   
Fx inflow Rs m6,5634,952 132.6%   
Fx outflow Rs m3,012697 432.2%   
Net fx Rs m3,5524,255 83.5%   
CASH FLOW
From Operations Rs m7,2592,786 260.5%  
From Investments Rs m1,864-1,529 -121.9%  
From Financial Activity Rs m-9,273-941 985.3%  
Net Cashflow Rs m-150316 -47.4%  

Share Holding

Indian Promoters % 66.9 61.4 109.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 3.7 894.6%  
FIIs % 0.0 12.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 22.1 -  
Shareholders   68,381 46,261 147.8%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   GLENMARK PHARMA  FULFORD INDIA  MERCK LTD  AJANTA PHARMA  UNICHEM LAB  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 23, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 8-QTR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS